Aerie Pharmaceuticals Receives FDA Approval of Rocklatan for Reduction of IOP
Netarsudil Rhopressa Ophthalmic Solution - Dose, Side effects
Medications - Glaucoma Institute New Jersey NJ
These highlights do not include all the information needed to use RHOPRESSA® safely and effectively. See full prescribing information for RHOPRESSA®. RHOPRESSA® (netarsudil ophthalmic solution) 0.02%, for topical ophthalmic use Initial U.S.
Company Overview
New Drug Rhopressa Now Available for Open-Angle Glaucoma | glaucoma.org